Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

AZN

Astrazeneca plc ADR

Sep 09 • 02:36PM ET

80.91

Dollar change -2.14
Percentage change -2.58	%

Healthcare • Drug Manufacturers - General • United Kingdom • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: QQQ QQQM DFIC PPH AVDE TQQQ QYLD QQEW DFAX DIHP

Scroll to Statements

Index	NDX	P/E	39.20	EPS (ttm)	2.06	Insider Own	0.03%	Shs Outstand	3.10B	Perf Week	-7.66%
Market Cap	250.86B	Forward P/E	17.06	EPS next Y	4.74	Insider Trans	0.00%	Shs Float	3.10B	Perf Month	-1.15%
Income	6.44B	PEG	2.99	EPS next Q	1.05	Inst Own	16.26%	Short Float	0.27%	Perf Quarter	1.11%
Sales	49.13B	P/S	5.11	EPS this Y	12.85%	Inst Trans	-2.07%	Short Ratio	2.06	Perf Half Y	21.67%
Book/sh	12.74	P/B	6.35	EPS next Y	15.74%	ROA	6.41%	Short Interest	8.51M	Perf Year	18.98%
Cash/sh	2.28	P/C	35.45	EPS next 5Y	13.10%	ROE	16.75%	52W Range	60.47 - 87.68	Perf YTD	20.13%
Dividend Est.	1.55 (1.92%)	P/FCF	25.65	EPS past 5Y	17.72%	ROI	9.51%	52W High	-7.72%	Beta	0.50
Dividend TTM	1.48 (1.84%)	Quick Ratio	0.69	Sales past 5Y	16.24%	Gross Margin	74.22%	52W Low	33.80%	ATR (14)	1.51
Dividend Ex-Date	Aug 09, 2024	Current Ratio	0.89	EPS Y/Y TTM	4.49%	Oper. Margin	19.09%	RSI (14)	36.89	Volatility	1.45% 1.17%
Employees	89900	Debt/Eq	0.85	Sales Y/Y TTM	10.45%	Profit Margin	13.11%	Recom	1.70	Target Price	92.58
Option/Short	Yes / Yes	LT Debt/Eq	0.71	EPS Q/Q	5.99%	Payout	73.87%	Rel Volume	1.80	Prev Close	83.05
Sales Surprise	2.48%	EPS Surprise	0.74%	Sales Q/Q	13.33%	Earnings	Jul 25 BMO	Avg Volume	4.14M	Price	80.91
SMA20	-4.92%	SMA50	-0.44%	SMA200	11.56%	Trades		Volume	5,942,042	Change	-2.58%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-24	Initiated	Goldman	Buy	$97
Apr-16-24	Upgrade	Deutsche Bank	Sell → Hold
Feb-08-24	Downgrade	Deutsche Bank	Hold → Sell
Jan-23-24	Initiated	Morgan Stanley	Overweight	$85
Jan-16-24	Resumed	UBS	Sell
Jan-03-24	Downgrade	Jefferies	Buy → Hold	$78.50 → $70
Dec-18-23	Initiated	HSBC Securities	Buy	$78
Sep-25-23	Upgrade	Jefferies	Hold → Buy	$66.50 → $80
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-12-23	Upgrade	UBS	Neutral → Buy
Jul-05-23	Downgrade	Deutsche Bank	Buy → Hold
Apr-11-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jan-05-23	Initiated	BMO Capital Markets	Outperform	$82
Sep-15-22	Downgrade	Credit Suisse	Outperform → Neutral
Sep-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-29-22	Upgrade	Argus	Hold → Buy	$75
Jun-14-22	Downgrade	UBS	Buy → Neutral
Feb-11-22	Upgrade	DZ Bank	Sell → Hold
Dec-07-21	Downgrade	Jefferies	Buy → Hold
Aug-12-21	Resumed	JP Morgan	Overweight

Show Previous Ratings

Today 02:05PM	Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst (Benzinga)
01:50PM	Datopotamab deruxtecan showed median overall survival of 14.6 months in patients with advanced nonsquamous non-small cell lung cancer in TROPION-Lung01 Phase III trial (Business Wire)
01:00AM	Innate Pharma SA:Monalizumab Data From NeoCOAST-2 Phase 2 Study in Early-Stage NSCLC Presented at the WCLC 2024 (Business Wire)
Sep-08-24 12:25PM	Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lung cancer in TROPION-Lung01 Phase III trial (Business Wire)
Sep-06-24 05:15AM	3 Market-Beating Stocks to Buy for Less Than $100 (Motley Fool)
02:56PM	Loading…
Sep-05-24 02:56PM	AstraZeneca Employees Held in China for Data Privacy, Drug-Import Investigations (Investopedia)
02:56PM	AstraZeneca Employees Held in China for Drug-Import, Data Privacy Investigations (Investopedia)
01:37PM	AstraZeneca In Trouble For Employee Detentions in China Over Illegal Activities (Benzinga)
09:00AM	China Detains AstraZeneca Employees Over Alleged Transport of Unapproved Drug (The Wall Street Journal)
04:50AM	AstraZeneca says small number of employees under investigation in China (Financial Times)
04:50AM	AstraZeneca staff detained in China amid claims of illegal drug imports (The Telegraph)
03:42AM	China Detains AstraZeneca Staff in Data, Drug-Import Probes (Bloomberg)
Sep-04-24 07:33AM	EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity (Benzinga)
Sep-03-24 11:32PM	Is AstraZeneca PLC (AZN) the Best Cancer Stock to Buy Now? (Insider Monkey)
07:00AM	AstraZeneca advances ambition to improve standards of care in multiple cancer types at WCLC and ESMO 2024 (Business Wire)
01:08AM	Loading…
01:08AM	Several Reasons for the Outperformance of Astrazeneca Plc (AZN) (Insider Monkey)
Sep-02-24 05:07PM	AstraZeneca PLC (AZN): A Good 52-Week High Stock to Buy According to Short Sellers (Insider Monkey)
Sep-01-24 10:08PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
Aug-31-24 02:52PM	Diabetes duration has minimal impact on SGLT2 inhibitor efficacy, as per new analysis (Pharmaceutical Technology)
Aug-29-24 06:00AM	Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer (MedTech Dive)
Aug-28-24 12:36PM	AstraZeneca PLC (AZN): A Cheap Pharmaceutical Stock to Buy According to Short Sellers (Insider Monkey)
Aug-26-24 11:18AM	AstraZeneca (AZN) Denies Rumors About UK Facility Relocation (Zacks)
Aug-23-24 12:23PM	AstraZeneca may pull plug on UK vaccine manufacturing plans (Pharmaceutical Technology)
08:39AM	AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support (Benzinga)
Aug-22-24 04:10PM	AstraZeneca warns of shifting UK vaccine production to US, FT reports (Reuters)
04:10PM	AstraZeneca warns of moving UK vaccine production to US, FT reports (Reuters)
04:10PM	AstraZeneca threatens to move UK vaccine production to US, FT reports (Reuters)
Aug-21-24 12:42AM	Covid-19: vaccine pricing varies wildly by country and company (Pharmaceutical Technology)
Aug-20-24 02:30PM	Heard Writers Pick Their Favorite and Least-Favorite Stocks (The Wall Street Journal)
07:53AM	J&J drug combo for lung cancer approved by FDA (BioPharma Dive)
07:00AM	Loading…
07:00AM	AstraZeneca Is a Cancer Leader. Obesity Could Be a Bonus. (The Wall Street Journal)
Aug-19-24 07:42AM	EMA validates Type II Variation application for ENHERTU for breast cancer treatment (Pharmaceutical Business Review)
06:33AM	Daiichi Sankyo-AstraZenecas ENHERTU gains BTD for breast cancer (Pharmaceutical Technology)
Aug-17-24 08:09AM	AIM ImmunoTech Inc. (AMEX:AIM) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-16-24 01:21PM	How Should You Play AstraZeneca (AZN) After Q2 Beat, View Raise? (Zacks)
11:15AM	FDA Expands AstraZeneca's (AZN) Imfinzi Label in Lung Cancer (Zacks)
11:03AM	AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting (Pharmaceutical Technology)
08:51AM	FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer (Benzinga)
07:00AM	IMFINZI (durvalumab) approved in the US for the treatment of resectable non-small cell lung cancer before and after surgery (Business Wire)
04:32AM	AstraZenecas sBLA for LS-SCLC treatment gains FDA priority review (Pharmaceutical Technology)
Aug-15-24 05:30PM	These 10 drugs will be cheaper after Medicare negotiations (Yahoo Finance Video)
04:04PM	Medicare Slashes Merck, Novo, AstraZeneca Drug Prices Up To 79% In IRA Negotiations (Investor's Business Daily)
12:34PM	Medicare negotiates lower prices for 10 high-cost drugs (Yahoo Finance Video)
10:49AM	Big Pharma: The government revealed its list of negotiated drug prices. Here are the reactions. (Yahoo Finance)
07:49AM	Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations (Yahoo Finance)
07:00AM	IMFINZI (durvalumab) granted Priority Review and Breakthrough Therapy Designation for patients with limited-stage small cell lung cancer in the US (Business Wire)
06:25AM	AstraZeneca (AZN) Imfinzi Combo Gets EU Nod for Uterine Cancer (Zacks)
Aug-14-24 11:51PM	George Soros Amplifies S&P 500 ETF Trust Holdings in Q2 2024 (GuruFocus.com)
05:42PM	Health Care Roundup: Market Talk (The Wall Street Journal)
06:15AM	3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct (InvestorPlace)
05:29AM	AstraZenecas new £450m UK vaccine hub under threat from Reeves state aid review (The Telegraph)
04:48AM	Drugmaker AstraZenecas Market Value Soars Past £200 Billion (Bloomberg)
04:12AM	China approves AstraZeneca-Daiichi Sankyos gastric cancer therapy (Pharmaceutical Technology)
Aug-13-24 02:43PM	Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows (Benzinga)
01:30PM	AstraZeneca becomes Britains first £200bn company (The Telegraph)
Aug-12-24 05:52AM	Era of ADCs: Pharma companies innovate to stand out in a buzzing market (Pharmaceutical Technology)
Aug-10-24 03:14PM	Why Is AstraZeneca PLC (AZN) a Good Addition to Your Stock Portfolio Now? (Insider Monkey)
Aug-09-24 07:00PM	10 Best Undervalued UK Stocks To Buy Now (Insider Monkey)
Aug-08-24 08:23PM	AstraZeneca PLC (AZN): Should You Invest in This GLP-1 and Weight Loss Stock Right Now? (Insider Monkey)
12:33PM	Conduit acquires three first-in-class assets from AstraZeneca (Pharmaceutical Technology)
06:00AM	EXCLUSIVE: Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets (Benzinga)
Aug-04-24 10:07AM	Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market (Motley Fool)
Aug-02-24 09:20AM	Heres Why AstraZeneca PLC (AZN) Increased in Q2 (Insider Monkey)
04:34AM	Q2 2024 Ionis Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-01-24 12:58PM	Q2 2024 Paysign Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-30-24 04:32AM	AstraZeneca reports positive data from chronic lymphocytic leukaemia therapy trial (Clinical Trials Arena)
04:12AM	NICE not to recommend Daiichi Sankyo-AstraZenecas Enhertu for NHS (Pharmaceutical Technology)
Jul-29-24 07:00AM	Fixed-duration CALQUENCE (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial (Business Wire)
Jul-26-24 12:54PM	FDA committee proposes overhaul of perioperative lung cancer trials (Pharmaceutical Technology)
12:25PM	3 Surprisingly Underrated Stocks to Buy Right Now (Motley Fool)
01:00AM	AstraZeneca CEO talks dual supply chain strategy (Yahoo Finance Video)
Jul-25-24 04:07PM	AstraZeneca Says It Has A 'Powerful' And Differentiated Approach To Obesity Treatment (Investor's Business Daily)
03:34PM	Analyst Report: AstraZeneca PLC (Morningstar Research)
02:21PM	US economy keeps growing, Astrazeneca CEO describes challenges: Catalysts (Yahoo Finance Video)
02:08PM	AstraZeneca CEO: We're building '2 supply chains' to avoid impact of US-China tensions (Yahoo Finance)
12:27PM	AstraZeneca CEO on revenue beat (CNBC TV)
11:48AM	Why AstraZeneca Stock Is Sliding Today (Motley Fool)
11:45AM	AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript (Motley Fool)
11:43AM	Why AstraZeneca's CEO isn't worried about costs (Yahoo Finance Video)
11:09AM	AstraZeneca Makes A Bearish Move Despite Quarterly Beat As FDA Panel Mulls Cancer Drug (Investor's Business Daily)
09:30AM	Astrazeneca (AZN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
09:28AM	NHS spending rules risk depriving Britain of new medicine, warns AstraZeneca boss (The Telegraph)
09:28AM	NHS rules risk depriving Britain of new medicine, warns AstraZeneca boss (The Telegraph)
09:20AM	AstraZeneca Slides Despite Beating Quarterly Expectations And Hiking Its Outlook (Investor's Business Daily)
09:19AM	AstraZeneca Posts Mixed Q2 Earnings, Still Raises Annual Guidance On Strong Demand For Cancer, Rare Disease Medicines (Benzinga)
09:05AM	AstraZeneca (AZN) Beats on Q2 Earnings & Sales, Ups '24 View (Zacks)
08:53AM	AstraZeneca Posts Earnings Beat, Lifts Guidance on Strong Sales (Investopedia)
07:33AM	Trials to watch: Four biologics concluding pivotal COPD trials (Clinical Trials Arena)
07:00AM	AstraZenecas H1 and Q2 2024 Financial Results (Business Wire)
05:06AM	Astrazeneca: Q2 Earnings Snapshot (Associated Press Finance)
04:07AM	AstraZeneca shares fall despite guidance raise as drugmaker warns on income (Investing.com)
02:50AM	AstraZeneca Raises Guidance After Revenue, Earnings Beat Market Expectations (The Wall Street Journal)
02:07AM	AstraZeneca raises profit outlook on strong medicines demand (Reuters)
Jul-24-24 06:08PM	Earnings from American & Southwest, Q2 GDP data: What to watch (Yahoo Finance Video)
10:13AM	AstraZeneca grows oncology portfolio with Pinetrees EGFR degrader (Pharmaceutical Technology)
Jul-23-24 03:04PM	Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants (Benzinga)
11:17AM	Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca (PR Newswire)
07:00AM	Voydeya approved in Canada as add-on therapy to ravulizumab or eculizumab for adults with the rare disease PNH who have residual hemolytic anemia due to extravascular hemolysis (PR Newswire)
Jul-22-24 10:47AM	Is AstraZeneca (AZN) a Portfolio Must-Have Pre-Q2 Earnings? (Zacks)
01:12AM	Enhertu set to become a blockbuster drug after outperforming Kadcyla (Clinical Trials Arena)

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc ADR

Upgrade your FINVIZ experience